Mainstream

Pra Group Targets $1.2b Portfolio Purchases In 2025 With Focus On Cash Collection Growth

PRA Group targets $1.2B portfolio purchases in 2025 with focus on cash collection growth

PRA Group targets $1.2B portfolio purchases in 2025 with focus on cash collection growth

Post ContentpraaRead More

You might also be interested in reading Silexion Therapeutics announces exercise of warrants for $3.3M gross proceeds.

February 20, 2025
In Mainstream